Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system
出版年份 2018 全文链接
标题
Resveratrol ameliorates maternal and post-weaning high-fat diet-induced nonalcoholic fatty liver disease via renin-angiotensin system
作者
关键词
Nonalcoholic fatty liver disease (NAFLD), High-fat diet, Resveratrol, Renin-angiotensin system (RAS)
出版物
Lipids in Health and Disease
Volume 17, Issue 1, Pages -
出版商
Springer Nature
发表日期
2018-07-28
DOI
10.1186/s12944-018-0824-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Actein ameliorates hepatic steatosis and fibrosis in high fat diet-induced NAFLD by regulation of insulin and leptin resistant
- (2018) Hong-Jun Chen et al. BIOMEDICINE & PHARMACOTHERAPY
- Nonalcoholic Fatty Liver Disease and Risk of Incident Type 2 Diabetes: A Meta-analysis
- (2018) Alessandro Mantovani et al. DIABETES CARE
- Hypertension, diabetes, atherosclerosis and NASH: Cause or consequence?
- (2018) Amedeo Lonardo et al. JOURNAL OF HEPATOLOGY
- Emerging roles of SIRT1 in fatty liver diseases
- (2017) Ren-Bo Ding et al. International Journal of Biological Sciences
- Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis
- (2016) Stefano Ballestri et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Lipid disorder and intrahepatic renin-angiotensin system activation synergistically contribute to non-alcoholic fatty liver disease
- (2016) Yu Wu et al. LIVER INTERNATIONAL
- The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
- (2016) Elena Buzzetti et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Sirtuins and nonalcoholic fatty liver disease
- (2016) Fatiha Nassir et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Hepatic Macrosteatosis Is Partially Converted to Microsteatosis by Melatonin Supplementation in ob/ob Mice Non-Alcoholic Fatty Liver Disease
- (2016) Alessandra Stacchiotti et al. PLoS One
- Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
- (2016) Takaomi Kessoku et al. Scientific Reports
- The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study
- (2015) Forouzan Faghihzadeh et al. BRITISH JOURNAL OF NUTRITION
- Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: A randomized controlled trial
- (2015) Shihui Chen et al. DIGESTIVE AND LIVER DISEASE
- Fucoidan ameliorates steatohepatitis and insulin resistance by suppressing oxidative stress and inflammatory cytokines in experimental non-alcoholic fatty liver disease
- (2015) Gehan H. Heeba et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
- (2015) Glenn Simmons et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Jinlida reduces insulin resistance and ameliorates liver oxidative stress in high-fat fed rats
- (2015) Yixuan Liu et al. JOURNAL OF ETHNOPHARMACOLOGY
- Resveratrol Does Not Benefit Patients With Nonalcoholic Fatty Liver Disease
- (2014) Veronique S. Chachay et al. Clinical Gastroenterology and Hepatology
- Resveratrol supplementation improves inflammatory biomarkers in patients with nonalcoholic fatty liver disease
- (2014) Forouzan Faghihzadeh et al. NUTRITION RESEARCH
- Angiotensin 1–7: A peptide for preventing and treating metabolic syndrome
- (2014) Sérgio Henrique Sousa Santos et al. PEPTIDES
- The role of renin-angiotensin system modulation on treatment and prevention of liver diseases
- (2014) Simone Moreira de Macêdo et al. PEPTIDES
- SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
- (2013) Yasar Colak et al. MEDICAL SCIENCE MONITOR
- High Fat Diet Induces Liver Steatosis and Early Dysregulation of Iron Metabolism in Rats
- (2013) Rosaria Meli et al. PLoS One
- Adipokines Mediate Inflammation and Insulin Resistance
- (2013) Hyokjoon Kwon et al. Frontiers in Endocrinology
- SIRT1 and energy metabolism
- (2012) X. Li ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Hepatic Steatosis Index and Lipid Accumulation Product as middle-term predictors of incident metabolic syndrome in a large population sample: data from the Brisighella Heart Study
- (2012) Arrigo F. G. Cicero et al. Internal and Emergency Medicine
- Decreased hepatic gluconeogenesis in transgenic rats with increased circulating angiotensin-(1-7)
- (2012) Victor Bilman et al. PEPTIDES
- Negative regulation of inflammation by SIRT1
- (2012) Jun Xie et al. PHARMACOLOGICAL RESEARCH
- Is alanine aminotransferase level a surrogate biomarker of hepatic apoptosis in nonalcoholic fatty liver disease?
- (2010) Billur Canbakan et al. Biomarkers in Medicine
- ACE2 and Diabetes: ACE of ACEs?
- (2010) D. Batlle et al. DIABETES
- Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
- (2009) Aparna Purushotham et al. Cell Metabolism
- Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors
- (2009) Mao-liang Huang et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Metabolic benefits from Sirt1 and Sirt1 activators
- (2009) Nilika Chaudhary et al. CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE
- Recent advances in the angiotensin-converting enzyme 2-angiotensin(1-7)-Mas axis
- (2008) Robson A. S. Santos et al. EXPERIMENTAL PHYSIOLOGY
- Sirt1 protects against high-fat diet-induced metabolic damage
- (2008) P. T. Pfluger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started